BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 110 filers reported holding BIONTECH SE in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,457,413 | -34.2% | 464,446 | -34.6% | 0.01% | -37.5% |
| Q2 2023 | $76,641,956 | +14.9% | 710,108 | +32.6% | 0.02% | +6.7% |
| Q1 2023 | $66,730,779 | -64.0% | 535,689 | -56.6% | 0.02% | -65.9% |
| Q4 2022 | $185,460,260 | +20.0% | 1,234,591 | +7.8% | 0.04% | +25.7% |
| Q3 2022 | $154,537,000 | -45.6% | 1,145,741 | -39.9% | 0.04% | -52.1% |
| Q2 2022 | $284,183,000 | -18.5% | 1,905,985 | -6.8% | 0.07% | +1.4% |
| Q1 2022 | $348,795,000 | -45.5% | 2,044,997 | -17.6% | 0.07% | -45.0% |
| Q4 2021 | $640,141,000 | -33.7% | 2,483,092 | -29.8% | 0.13% | -34.8% |
| Q3 2021 | $965,976,000 | +137.4% | 3,538,500 | +94.7% | 0.20% | +120.9% |
| Q2 2021 | $406,872,000 | +140.2% | 1,817,368 | +17.1% | 0.09% | +122.0% |
| Q1 2021 | $169,423,000 | +137.7% | 1,551,633 | +77.5% | 0.04% | +127.8% |
| Q4 2020 | $71,261,000 | +111.5% | 874,138 | +79.6% | 0.02% | +80.0% |
| Q3 2020 | $33,690,000 | +26.6% | 486,646 | +22.0% | 0.01% | +11.1% |
| Q2 2020 | $26,613,000 | – | 398,761 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |